187 related articles for article (PubMed ID: 37559530)
1. Effects of caffeine therapy for apnea of prematurity on sleep and neurodevelopment of preterm infants at 6 months of corrected age.
Atalah YEY; Barış HE; Akdere SK; Sabancı M; Özdemir H; Gücüyener K; Eralp EE; Özek E; Boran P
J Clin Sleep Med; 2023 Dec; 19(12):2075-2085. PubMed ID: 37559530
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of caffeine therapy for apnea of prematurity on sleep at school age.
Marcus CL; Meltzer LJ; Roberts RS; Traylor J; Dix J; D'ilario J; Asztalos E; Opie G; Doyle LW; Biggs SN; Nixon GM; Narang I; Bhattacharjee R; Davey M; Horne RS; Cheshire M; Gibbons J; Costantini L; Bradford R; Schmidt B;
Am J Respir Crit Care Med; 2014 Oct; 190(7):791-9. PubMed ID: 25171195
[TBL] [Abstract][Full Text] [Related]
3. Sleep assessment in preterm infants: Use of actigraphy and aEEG.
Ülgen Ö; Barış HE; Aşkan ÖÖ; Akdere SK; Ilgın C; Özdemir H; Bekiroğlu N; Gücüyener K; Özek E; Boran P
Sleep Med; 2023 Jan; 101():260-268. PubMed ID: 36459917
[TBL] [Abstract][Full Text] [Related]
4. Validation of actigraphy for determining sleep and wake in preterm infants.
Sung M; Adamson TM; Horne RS
Acta Paediatr; 2009 Jan; 98(1):52-7. PubMed ID: 18754828
[TBL] [Abstract][Full Text] [Related]
5. Long-term neurodevelopment outcome of caffeine versus aminophylline therapy for apnea of prematurity.
Khurana S; Shivakumar M; Sujith Kumar Reddy GV; Jayashree P; Ramesh Bhat Y; Lewis LES
J Neonatal Perinatal Med; 2017; 10(4):355-362. PubMed ID: 29286928
[TBL] [Abstract][Full Text] [Related]
6. Actigraphy is not a reliable method for measuring sleep patterns in neonates.
Rioualen S; Roué JM; Lefranc J; Gouillou M; Nowak E; Alavi Z; Dubourg M; Sizun J
Acta Paediatr; 2015 Nov; 104(11):e478-82. PubMed ID: 26081297
[TBL] [Abstract][Full Text] [Related]
7. Sleep-disordered breathing, craniofacial development, and neurodevelopment in premature infants: a 2-year follow-up study.
Huang YS; Hsu JF; Paiva T; Chin WC; Chen IC; Guilleminault C
Sleep Med; 2019 Aug; 60():20-25. PubMed ID: 30466820
[TBL] [Abstract][Full Text] [Related]
8. Methylxanthine for the prevention and treatment of apnea in preterm infants.
Marques KA; Bruschettini M; Roehr CC; Davis PG; Fiander M; Soll R
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013830. PubMed ID: 37905735
[TBL] [Abstract][Full Text] [Related]
9. Caffeine and supplemental oxygen effectively suppress periodic breathing with only minor effects during long episodes of apnoea in preterm infants.
Seppä-Moilanen M; Andersson S; Rantakari K; Mikkola K; Kirjavainen T
Acta Paediatr; 2019 Mar; 108(3):443-451. PubMed ID: 30118174
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of caffeine therapy for apnea of prematurity.
Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
N Engl J Med; 2007 Nov; 357(19):1893-902. PubMed ID: 17989382
[TBL] [Abstract][Full Text] [Related]
11. Validation of photoplethysmography- and acceleration-based sleep staging in a community sample: comparison with polysomnography and Actiwatch.
Liu PK; Ting N; Chiu HC; Lin YC; Liu YT; Ku BW; Lee PL
J Clin Sleep Med; 2023 Oct; 19(10):1797-1810. PubMed ID: 37338335
[TBL] [Abstract][Full Text] [Related]
12. Polysomnography use in complex term and preterm infants to facilitate evaluation and management in the neonatal intensive care unit.
Kim J; Gueye-Ndiaye S; Mauer E; Modi VK; Perlman J; Veler H
J Clin Sleep Med; 2021 Aug; 17(8):1653-1663. PubMed ID: 33755011
[TBL] [Abstract][Full Text] [Related]
13. Developmental care does not alter sleep and development of premature infants.
Ariagno RL; Thoman EB; Boeddiker MA; Kugener B; Constantinou JC; Mirmiran M; Baldwin RB
Pediatrics; 1997 Dec; 100(6):E9. PubMed ID: 9382910
[TBL] [Abstract][Full Text] [Related]
14. Validation of a Consumer Sleep Wearable Device With Actigraphy and Polysomnography in Adolescents Across Sleep Opportunity Manipulations.
Lee XK; Chee NIYN; Ong JL; Teo TB; van Rijn E; Lo JC; Chee MWL
J Clin Sleep Med; 2019 Sep; 15(9):1337-1346. PubMed ID: 31538605
[TBL] [Abstract][Full Text] [Related]
15. Caffeine is a respiratory stimulant without effect on sleep in the short-term in late-preterm infants.
Seppä-Moilanen M; Andersson S; Kirjavainen T
Pediatr Res; 2022 Sep; 92(3):776-782. PubMed ID: 34718352
[TBL] [Abstract][Full Text] [Related]
16. Sound reduction management in the neonatal intensive care unit for preterm or very low birth weight infants.
Almadhoob A; Ohlsson A
Cochrane Database Syst Rev; 2015 Jan; 1():CD010333. PubMed ID: 25633155
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic versus therapeutic caffeine for apnea of prematurity: a randomized controlled trial.
Elmowafi M; Mohsen N; Nour I; Nasef N
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6053-6061. PubMed ID: 33771081
[TBL] [Abstract][Full Text] [Related]
18. Early Caffeine Administration and Neurodevelopmental Outcomes in Preterm Infants.
Lodha A; Entz R; Synnes A; Creighton D; Yusuf K; Lapointe A; Yang J; Shah PS;
Pediatrics; 2019 Jan; 143(1):. PubMed ID: 30518670
[TBL] [Abstract][Full Text] [Related]
19. Neurodevelopment at 2 years corrected age among Vietnamese preterm infants.
Do CHT; Kruse AY; Wills B; Sabanathan S; Clapham H; Pedersen FK; Pham TN; Vu PM; Børresen ML
Arch Dis Child; 2020 Feb; 105(2):134-140. PubMed ID: 31300408
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic methylxanthine for prevention of apnoea in preterm infants.
Henderson-Smart DJ; De Paoli AG
Cochrane Database Syst Rev; 2010 Dec; 2010(12):CD000432. PubMed ID: 21154344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
